HF
PRME icon

HRT Financial’s Prime Medicine PRME Stock Holding History

HRT Financial’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Sell
161,510
-451,259
-74% -$1.5M ﹤0.01% 2516
2026
Q1 		$2.13M Sell
612,769
-42,582
-6% -$162K 0.01% 1581
2025
Q4 		$2.27M Buy
655,351
+433,887
+196% +$1.93M 0.01% 1222
2025
Q3 		$1.23M Buy
221,464
+157,297
+245% +$639K ﹤0.01% 1421
2025
Q2 		$158K Buy
+64,167
New +$98.9K ﹤0.01% 2125
2025
Q1 		– Sell
-21,695
Closed -$63K – 3215
2024
Q4 		$63K Buy
+21,695
New +$76.2K ﹤0.01% 2088
2024
Q2 		– Sell
-41,000
Closed -$287K – 2917
2024
Q1 		$287K Sell
41,000
-18,116
-31% -$137K ﹤0.01% 1582
2023
Q4 		$523K Buy
+59,116
New +$455K ﹤0.01% 1337

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HRT Financial's PRME Position: Q2 2026 in Review

HRT Financial reduced its Prime Medicine (PRME) stake by 74% in Q2 2026, selling an estimated $1.5M and leaving 161,510 shares worth $595K. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

HRT Financial first reported a position in PRME in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.27M in Q4 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • HRT Financial held 161,510 shares of Prime Medicine worth $595K as of Q2 2026.
  • HRT Financial sold 451,259 Prime Medicine shares in Q2 2026, an estimated $1.5M.
  • Prime Medicine made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2516 holding.
  • HRT Financial first reported a position in Prime Medicine in Q4 2023 and has held it in 8 quarters since.
  • HRT Financial's Prime Medicine position peaked at $2.27M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.